Detail akcie Augmedix Rg online

Business Summary: Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Augmedix Inc revenues increased 45% to $44.9M. Net loss decreased 22% to $19.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Loss on debt extinguishment decrease from $1.1M (expense) to $0K, Interest income increase from $245K to $1.1M (income), Other income increase of 79% to $1M (income).